Michela Gabaldo

Head Alliance Management & Regulatory Affairs • Fondazione Telethon

Michela Gabaldo is Head, Alliance Management & Regulatory Affairs at Fondazione Telethon in Milan (Italy). She is an talented leader and expert in regulatory affairs with more than 20 years experience in drug development . She’s currently supporting the 2 internal Scientific Institutes in Italy, SR-TIGET (San Raffaele-Telethon Institute for gene therapy in Milan) and TIGEM (in Naples) in providing global strategic direction in regulatory affairs for the progression of gene therapy (ex-vivo and in-vivo) and gene editing projects tackling rare genetic disease at different stages of development spanning from research and pre-clinical up to patient access. These programs are developed both internally and in partnership with relevant pharmaceutical industries or through start-ups. Within this role she’s been actively involved in the development and access of the 1st ex-vivo gene therapy registered worldwide – Strimvelis – in 2016 and in the Libmeldy program who has reached recently the EU approval. 

Also speaking

Alan Griffith

Vice President of Research • PureSpring Therapeutics

Nicholas Medcalf

Deputy Challenge Director for the Medicines Manufacturing Challenge • Innovate UK

Mark Trusheim

Strategic Director, NEWDIGS and Visiting Scientist, • Massachusetts Institute of Technology (MIT)

Event Info


Spotlight Roundtables

Take a look at the sample attendee list for Advanced Therapies Europe here.

Pub & Pints RSVP

Let us know you’re planning on attending.